Yüklüyor......
Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer
BACKGROUND: Programmed cell death ligand 1 (PD-L1) is a potential predictive biomarker of the response to anti-PD-L1/anti- programmed cell death 1 (PD-1) therapy in multiple cancers, including triple negative breast cancer(TNBC). The purpose of this study was to investigate whether PD-L1 expression...
Kaydedildi:
| Yayımlandı: | BMC Cancer |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5748959/ https://ncbi.nlm.nih.gov/pubmed/29291717 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3916-y |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|